Fairfield, Bush & Co. Merck & Co., Inc. Transaction History

Fairfield, Bush & Co.

$168 Billion
Q3 2024

A detailed history of Fairfield, Bush & Co. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Fairfield, Bush & Co. holds 11,186 shares of MRK stock, worth $1.11 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

11,186

Previous 11,766 4.93%

Holding current value

$1.11 Million

Previous $1.46 Billion 12.79%

% of portfolio

0.76%

Previous 0.87%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$111.15 - $128.97 $64,467 - $74,802	-580 Reduced 4.93%	11,186 $1.27 Billion
Q2 2024 Aug 15, 2024	SELL	$123.8 - $132.96 $26,740 - $28,719	-216 Reduced 1.8%	11,766 $1.46 Billion
Q1 2024 May 15, 2024	SELL	$113.24 - $131.95 $33,405 - $38,925	-295 Reduced 2.4%	11,982 $1.58 Billion
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $87,156 - $94,847	-870 Reduced 6.62%	12,277 $1.34 Billion
Q3 2023 Nov 15, 2023	SELL	$102.95 - $114.33 $1.07 Million - $1.19 Million	-10,375 Reduced 44.11%	13,147 $1.35 Billion
Q2 2023 Aug 15, 2023	BUY	$108.61 - $118.38 $13,793 - $15,034	127 Added 0.54%	23,522 $2.71 Billion
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $1.06 Million - $1.18 Million	10,284 Added 78.44%	23,395 $2.49 Billion
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $3,322 - $4,260	38 Added 0.29%	13,111 $1.45 Billion
Q3 2022 Nov 07, 2022	SELL	$84.53 - $94.96 $76,161 - $85,558	-901 Reduced 6.45%	13,073 $1.13 Million
Q2 2022 Aug 09, 2022	SELL	$83.49 - $94.64 $224,087 - $254,013	-2,684 Reduced 16.11%	13,974 $1.27 Million
Q1 2022 May 06, 2022	SELL	$73.51 - $82.4 $68,878 - $77,208	-937 Reduced 5.33%	16,658 $1.37 Million
Q4 2021 Feb 09, 2022	SELL	$72.28 - $90.54 $1.17 Million - $1.46 Million	-16,124 Reduced 47.82%	17,595 $1.35 Million
Q3 2021 Nov 08, 2021	SELL	$71.68 - $78.83 $484,915 - $533,284	-6,765 Reduced 16.71%	33,719 $2.53 Million
Q2 2021 Aug 02, 2021	SELL	$70.31 - $77.77 $101,246 - $111,988	-1,440 Reduced 3.43%	40,484 $3.15 Million
Q1 2021 May 14, 2021	SELL	$68.86 - $81.11 $47,995 - $56,533	-697 Reduced 1.64%	41,924 $3.08 Million
Q4 2020 Feb 12, 2021	BUY	$71.77 - $79.65 $14,928 - $16,567	208 Added 0.49%	42,621 $3.33 Million
Q3 2020 Nov 18, 2020	BUY	$73.18 - $82.95 $7,318 - $8,295	100 Added 0.24%	42,413 $3.36 Million
Q2 2020 Aug 13, 2020	BUY	$70.42 - $80.13 $1.48 Million - $1.68 Million	20,995 Added 98.48%	42,313 $3.27 Million
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $161,568 - $223,940	2,550 Added 13.59%	21,318 $1.64 Million
Q4 2019 Feb 12, 2020	BUY	$77.58 - $87.54 $135,765 - $153,195	1,750 Added 10.28%	18,768 $1.63 Million
Q3 2019 Nov 13, 2019	BUY	$76.08 - $82.93 $41,844 - $45,611	550 Added 3.34%	17,018 $1.43 Million
Q2 2019 Aug 13, 2019	BUY	$69.84 - $81.59 $153,648 - $179,498	2,200 Added 15.42%	16,468 $1.38 Million
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $139,160 - $158,720	2,000 Added 16.3%	14,268 $1.19 Million
Q4 2018 Feb 11, 2019	SELL	$65.24 - $75.71 $20,289 - $23,545	-311 Reduced 2.47%	12,268 $937,000
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $32,017 - $37,651	-555 Reduced 4.23%	12,579 $892,000
Q2 2018 Aug 16, 2018	SELL	$50.83 - $59.72 $18,044 - $21,200	-355 Reduced 2.63%	13,134 $797,000
Q1 2018 May 09, 2018	BUY	$50.96 - $59.23 $20,536 - $23,869	403 Added 3.08%	13,489 $735,000
Q4 2017 Feb 22, 2018	BUY	$51.62 - $61.64 $16,053 - $19,170	311 Added 2.43%	13,086 $736,000
Q2 2017 Aug 15, 2017	BUY	N/A	12,775	12,775 $819,000

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

News

Stay updated on Fairfield, Bush & Co. with notifications on news.

Account

Fairfield, Bush & Co. Merck & Co., Inc. Transaction History